What we should learn from the London Olympics
dc.contributor.author | Bonini M. | |
dc.contributor.author | Bachert C. | |
dc.contributor.author | Baena-Cagnani C.E. | |
dc.contributor.author | Bedbrook A. | |
dc.contributor.author | Brozek J.L. | |
dc.contributor.author | Canonica G.W. | |
dc.contributor.author | Cruz A.A. | |
dc.contributor.author | Fokkens W.J. | |
dc.contributor.author | Wijk R.G.V. | |
dc.contributor.author | Grouse L. | |
dc.contributor.author | Hellings P.W. | |
dc.contributor.author | Howarth P. | |
dc.contributor.author | Kalayci O. | |
dc.contributor.author | Khaltaev N. | |
dc.contributor.author | Kuna P. | |
dc.contributor.author | Linnemann D.L. | |
dc.contributor.author | Nekam K. | |
dc.contributor.author | Palkonen S. | |
dc.contributor.author | Papadopoulos N.G. | |
dc.contributor.author | Popov T.A. | |
dc.contributor.author | Price D. | |
dc.contributor.author | Pinto J.R. | |
dc.contributor.author | Rasi G. | |
dc.contributor.author | Ryan D. | |
dc.contributor.author | Samolinski B. | |
dc.contributor.author | Scadding G.K. | |
dc.contributor.author | Schünemann H.J. | |
dc.contributor.author | Thomas D.M. | |
dc.contributor.author | Triggiani M. | |
dc.contributor.author | Yorgancioglu A. | |
dc.contributor.author | Yusuf O.M. | |
dc.contributor.author | Zuberbier T. | |
dc.contributor.author | Pawankar R. | |
dc.contributor.author | Bousquet J. | |
dc.contributor.author | Bonini S. | |
dc.date.accessioned | 2024-07-22T08:18:42Z | |
dc.date.available | 2024-07-22T08:18:42Z | |
dc.date.issued | 2013 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.DOI-ID | 10.1097/ACI.0b013e32835c1b73 | |
dc.identifier.issn | 14736322 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17396 | |
dc.language.iso | English | |
dc.rights | All Open Access; Bronze Open Access | |
dc.subject | Athletes | |
dc.subject | Evidence-Based Practice | |
dc.subject | Humans | |
dc.subject | London | |
dc.subject | Prevalence | |
dc.subject | Rhinitis, Allergic, Perennial | |
dc.subject | Sports | |
dc.subject | allergen | |
dc.subject | antihistaminic agent | |
dc.subject | beta 2 adrenergic receptor stimulating agent | |
dc.subject | bronchodilating agent | |
dc.subject | corticosteroid | |
dc.subject | ephedrine | |
dc.subject | long acting drug | |
dc.subject | methylephedrine | |
dc.subject | pseudoephedrine | |
dc.subject | short acting drug | |
dc.subject | steroid | |
dc.subject | vasoconstrictor agent | |
dc.subject | accuracy | |
dc.subject | allergic rhinitis | |
dc.subject | article | |
dc.subject | asthma | |
dc.subject | athlete | |
dc.subject | bronchospasm | |
dc.subject | doping | |
dc.subject | drug urine level | |
dc.subject | exercise induced asthma | |
dc.subject | exercise induced bronchoconstriction | |
dc.subject | fatigue | |
dc.subject | game | |
dc.subject | human | |
dc.subject | humidity | |
dc.subject | pollutant | |
dc.subject | practice guideline | |
dc.subject | prevalence | |
dc.subject | priority journal | |
dc.subject | quality of life | |
dc.subject | respiratory tract disease | |
dc.subject | sedation | |
dc.subject | sensitization | |
dc.subject | side effect | |
dc.subject | temperature | |
dc.subject | training | |
dc.title | What we should learn from the London Olympics | |
dc.type | Article |